Source link : https://www.newshealth.biz/health-news/adalimumab-improves-blood-parameters-in-patients-with-hs/
TOPLINE: Treatment with adalimumab improves anemia, thrombocytosis, and leukocytosis in patients with hidradenitis suppurativa (HS), in clinical responders and nonresponders. METHODOLOGY: HS is a chronic inflammatory skin condition characterized by a high inflammatory burden and hematologic abnormalities such as anemia, leukocytosis, and thrombocytosis. Immunomodulatory therapy was previously found to improve hematologic abnormalities in a small […]
Author : News Health
Publish date : 2024-05-09 12:55:57
Copyright for syndicated content belongs to the linked Source.
Categories